Chinese biotech develops semaglutide spray as Novo Nordisk patent expires in China

A Chinese biotechnology company, Shanghai Shiling Pharmaceutical, plans to complete clinical trials by 2028 for a weight-loss nasal spray that uses semaglutide, the same active ingredient as Danish drugmaker Novo Nordisk’s …

Chinese biotech develops semaglutide spray as Novo Nordisk patent expires in China Read More

Bangkok–Denmark health partnership launches ‘City for Better Health’ initiative

The Bangkok Metropolitan Administration (BMA), the Royal Danish Embassy in Bangkok and Novo Nordisk Pharma Thailand have signed a Memorandum of Understanding to establish “Bangkok, City for Better Health”, a …

Bangkok–Denmark health partnership launches ‘City for Better Health’ initiative Read More